USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Carl Zeiss Meditec AG

USPTO PatentsView assignee record — 689 granted patents across 51 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

689
Total patents granted
51
CPC technology areas
15.9
Avg claims per patent
+8%
5-year filing velocity

Portfolio overview

Carl Zeiss Meditec AG has been granted 689 US utility patents between 2015 and 2025, placing Carl Zeiss Meditec AG at rank #650 across all assignees tracked by PlainPatent. This portfolio spans 51 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.9 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Carl Zeiss Meditec AG is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 62.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 358 grants, compared with 331 in the 2015–2019 window — a +8% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Carl Zeiss Meditec AG's 15.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 51 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Carl Zeiss Meditec AG against peers pursuing similar technology classes.

How does Carl compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Carl holds 689 patents — placing it at rank #650 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

405060708090 20152016201720182019202020212022202320242025 58
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Carl Zeiss Meditec AG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 64 9.3%
2016 62 9.0%
2017 57 8.3%
2018 68 9.9%
2019 80 11.6%
2020 55 8.0%
2021 73 10.6%
2022 59 8.6%
2023 49 7.1%
2024 64 9.3%
2025 58 8.4%

Which technologies does Carl Zeiss Meditec AG patent most?

Top 15 of 51 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#650

Across all tracked assignees

Innovation Score

62.6 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Carl Zeiss Meditec AG hold?
Carl Zeiss Meditec AG holds 689 US granted patents filed between 2015 and 2025, spanning 51 technology areas.
What is Carl Zeiss Meditec AG's Innovation Score?
Carl Zeiss Meditec AG has an Innovation Score of 62.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Carl Zeiss Meditec AG focus on?
Carl Zeiss Meditec AG's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 416 patents. The company has filed patents in 51 CPC subclasses total.
Is Carl Zeiss Meditec AG's patent filing rate increasing or decreasing?
Carl Zeiss Meditec AG's recent filing velocity is +8% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Carl Zeiss Meditec AG's patents?
Carl Zeiss Meditec AG's patents average 15.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Carl Zeiss Meditec AG patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope